Matches in Nanopublications for { ?s ?p "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238629.RASsNrciXChsjnt3bX-f0ss7ceUTxL4Z13hBlGqK1lO0s130_provenance.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.